These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

535 related articles for article (PubMed ID: 18403709)

  • 1. An agonist of toll-like receptor 5 has radioprotective activity in mouse and primate models.
    Burdelya LG; Krivokrysenko VI; Tallant TC; Strom E; Gleiberman AS; Gupta D; Kurnasov OV; Fort FL; Osterman AL; Didonato JA; Feinstein E; Gudkov AV
    Science; 2008 Apr; 320(5873):226-30. PubMed ID: 18403709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioprotective effect of newly synthesized toll-like receptor 5 agonist, KMRC011, in mice exposed to total-body irradiation.
    Kim JY; Park JH; Seo SM; Park JI; Jeon HY; Lee HK; Yoo RJ; Lee YJ; Woo SK; Lee WJ; Choi CM; Choi YK
    J Radiat Res; 2019 Jul; 60(4):432-441. PubMed ID: 31165150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medicine. Drug bestows radiation resistance on mice and monkeys.
    Bhattacharjee Y
    Science; 2008 Apr; 320(5873):163. PubMed ID: 18403680
    [No Abstract]   [Full Text] [Related]  

  • 4. Central role of liver in anticancer and radioprotective activities of Toll-like receptor 5 agonist.
    Burdelya LG; Brackett CM; Kojouharov B; Gitlin II; Leonova KI; Gleiberman AS; Aygun-Sunar S; Veith J; Johnson C; Haderski GJ; Stanhope-Baker P; Allamaneni S; Skitzki J; Zeng M; Martsen E; Medvedev A; Scheblyakov D; Artemicheva NM; Logunov DY; Gintsburg AL; Naroditsky BS; Makarov SS; Gudkov AV
    Proc Natl Acad Sci U S A; 2013 May; 110(20):E1857-66. PubMed ID: 23630282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like receptor 5 agonist CBLB502 induces radioprotective effects in vitro.
    Shi T; Li L; Zhou G; Wang C; Chen X; Zhang R; Xu J; Lu X; Jiang H; Chen J
    Acta Biochim Biophys Sin (Shanghai); 2017 Jun; 49(6):487-495. PubMed ID: 28407032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Harnessing the power of bacteria to protect the gut.
    Abreu MT
    N Engl J Med; 2008 Aug; 359(7):756-9. PubMed ID: 18703481
    [No Abstract]   [Full Text] [Related]  

  • 7. Toll-like receptor 5 agonist protects mice from dermatitis and oral mucositis caused by local radiation: implications for head-and-neck cancer radiotherapy.
    Burdelya LG; Gleiberman AS; Toshkov I; Aygun-Sunar S; Bapardekar M; Manderscheid-Kern P; Bellnier D; Krivokrysenko VI; Feinstein E; Gudkov AV
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):228-34. PubMed ID: 22000579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-radiation damage effect of polyethylenimine as a toll-like receptor 5 targeted agonist.
    Hu Z; Xing Y; Qian Y; Chen X; Tu J; Ren L; Wang K; Chen Z
    J Radiat Res; 2013 Mar; 54(2):243-50. PubMed ID: 23104900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NLRC4 Mutation in flagellin-derived peptide CBLB502 ligand-binding domain reduces the inflammatory response but not radioprotective activity.
    Lai L; Yang G; Yao X; Wang L; Zhan Y; Yu M; Yin R; Li C; Yang X; Ge C
    J Radiat Res; 2019 Nov; 60(6):780-785. PubMed ID: 31599956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toll-like Receptor Agonist CBLB502 Protects Against Radiation-induced Intestinal Injury in Mice.
    Wang Q; Duan J; Hong J; Ding K; Tai F; Zhu J; Fu H; Zheng X; Ge C
    In Vivo; 2024; 38(4):1636-1648. PubMed ID: 38936936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CBLB502, a Toll-like receptor 5 agonist, offers protection against radiation-induced male reproductive system damage in mice.
    Bai H; Sun F; Yang G; Wang L; Zhang Q; Zhang Q; Zhan Y; Chen J; Yu M; Li C; Yin R; Yang X; Ge C
    Biol Reprod; 2019 Jan; 100(1):281-291. PubMed ID: 30084935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptor 5 agonism protects mice from radiation pneumonitis and pulmonary fibrosis.
    Wang ZD; Qiao YL; Tian XF; Zhang XQ; Zhou SX; Liu HX; Chen Y
    Asian Pac J Cancer Prev; 2012; 13(9):4763-7. PubMed ID: 23167416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Toll-Like Receptor 5 Agonist Entolimod Mitigates Lethal Acute Radiation Syndrome in Non-Human Primates.
    Krivokrysenko VI; Toshkov IA; Gleiberman AS; Krasnov P; Shyshynova I; Bespalov I; Maitra RK; Narizhneva NV; Singh VK; Whitnall MH; Purmal AA; Shakhov AN; Gudkov AV; Feinstein E
    PLoS One; 2015; 10(9):e0135388. PubMed ID: 26367124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CBLB502, an agonist of Toll-like receptor 5, has antioxidant and scavenging free radicals activities in vitro.
    Li W; Ge C; Yang L; Wang R; Lu Y; Gao Y; Li Z; Wu Y; Zheng X; Wang Z; Zhang C
    Int J Biol Macromol; 2016 Jan; 82():97-103. PubMed ID: 26476243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A flagellin-derived toll-like receptor 5 agonist stimulates cytotoxic lymphocyte-mediated tumor immunity.
    Leigh ND; Bian G; Ding X; Liu H; Aygun-Sunar S; Burdelya LG; Gudkov AV; Cao X
    PLoS One; 2014; 9(1):e85587. PubMed ID: 24454895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of granulocyte colony-stimulating factor and interleukin-6 as candidate biomarkers of CBLB502 efficacy as a medical radiation countermeasure.
    Krivokrysenko VI; Shakhov AN; Singh VK; Bone F; Kononov Y; Shyshynova I; Cheney A; Maitra RK; Purmal A; Whitnall MH; Gudkov AV; Feinstein E
    J Pharmacol Exp Ther; 2012 Nov; 343(2):497-508. PubMed ID: 22837010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FG-4592 protected haematopoietic system from ionising radiation in mice.
    Wang Y; Cheng Y; Zhang P; Huang D; Zhai X; Feng Z; Fang D; Liu C; Du J; Cai J
    Immunology; 2024 Aug; 172(4):614-626. PubMed ID: 38685744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A TLR5 agonist enhances CD8(+) T cell-mediated graft-versus-tumor effect without exacerbating graft-versus-host disease.
    Ding X; Bian G; Leigh ND; Qiu J; McCarthy PL; Liu H; Aygun-Sunar S; Burdelya LG; Gudkov AV; Cao X
    J Immunol; 2012 Nov; 189(10):4719-27. PubMed ID: 23045613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toll-like receptors and radiation protection.
    Liu Z; Lei X; Li X; Cai JM; Gao F; Yang YY
    Eur Rev Med Pharmacol Sci; 2018 Jan; 22(1):31-39. PubMed ID: 29364499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Editing flagellin derivatives for exploration of potent radioprotective agents.
    Shi T; Jiang J; Gao M; Ma R; Chen X; Zhang R; Xu J; Wang W; Xu S; Liu X; Zheng H; Wang C; Li L; Li R
    Eur J Pharmacol; 2021 Sep; 907():174259. PubMed ID: 34153338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.